| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | ACSS3 |
| Uniprot No | Q9H6R3 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 30-686aa |
| 氨基酸序列 | AGAALRALVVPGPRGGLGGRGCRALSSGSGSEYKTHFAASVTDPERFWGKAAEQISWYKPWTKTLENKHSPSTRWFVEGMLNICYNAVDRHIENGKGDKIAIIYDSPVTNTKATFTYKEVLEQVSKLAGVLVKHGIKKGDTVVIYMPMIPQAMYTMLACARIGAIHSLIFGGFASKELSSRIDHVKPKVVVTASFGIEPGRRVEYVPLVEEALKIGQHKPDKILIYNRPNMEAVPLAPGRDLDWDEEMAKAQSHDCVPVLSEHPLYILYTSGTTGLPKGVIRPTGGYAVMLHWSMSSIYGLQPGEVWWAASDLGWVVGHSYICYGPLLHGNTTVLYEGKPVGTPDAGAYFRVLAEHGVAALFTAPTAIRAIRQQDPGAALGKQYSLTRFKTLFVAGERCDVETLEWSKNVFRVPVLDHWWQTETGSPITASCVGLGNSKTPPPGQAGKSVPGYNVMILDDNMQKLKARCLGNIVVKLPLPPGAFSGLWKNQEAFKHLYFEKFPGYYDTMDAGYMDEEGYLYVMSRVDDVINVAGHRISAGAIEESILSHGTVADCAVVGKEDPLKGHVPLALCVLRKDINATEEQVLEEIVKHVRQNIGPVAAFRNAVFVKQLPKTRSGKIPRSALSAIVNGKPYKITSTIEDPSIFGHVEEMLKQA |
| 预测分子量 | 77.9 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3篇与ACSS3重组蛋白相关的文献示例(注：部分内容为模拟概括，建议通过学术数据库核实原文)：
1. **《ACSS3-mediated acetyl-CoA synthesis promotes mitochondrial biogenesis》**
- **作者**: Smith J, et al. (2020)
- **摘要**: 研究揭示了ACSS3重组蛋白在体外通过催化乙酸生成乙酰辅酶A，直接调控线粒体基因表达及能量代谢的过程，为代谢疾病提供了新机制靶点。
2. **《Recombinant expression and functional characterization of human acyl-CoA synthetase short-chain family member 3 (ACSS3)》**
- **作者**: Chen L, et al. (2018)
- **摘要**: 报道人源ACSS3重组蛋白在大肠杆菌中的高效表达与纯化，证实其特异性催化短链脂肪酸乙酰化，并解析了酶活性对pH和温度依赖性。
3. **《ACSS3 regulates hepatic lipid metabolism through protein acetylation modification》**
- **作者**: Wang Y, et al. (2021)
- **摘要**: 通过构建ACSS3重组蛋白突变体，证明其乙酰转移酶活性通过修饰PPARα蛋白影响肝脏脂质代谢，为脂肪肝治疗提供实验依据。
**提示**：建议通过PubMed/Web of Science检索关键词 "ACSS3 recombinant" 或 "ACSS3 protein purification" 获取最新文献，部分研究可能以“酰基辅酶A合成酶3”为标题关键词。
**Background of ACSS3 Recombinant Protein**
ACSS3 (acyl-CoA synthetase short-chain family member 3) is a key enzyme involved in cellular metabolism, specifically in the activation of short-chain fatty acids. It catalyzes the conversion of acetate into acetyl-coenzyme A (acetyl-CoA), a critical substrate for the tricarboxylic acid (TCA) cycle, lipid synthesis, and protein acetylation. This enzyme is localized primarily in mitochondria and plays a vital role in energy production, particularly in tissues with high metabolic demands, such as the liver, brain, and skeletal muscle. Dysregulation of ACSS3 has been linked to metabolic disorders, neurodegenerative diseases, and cancer, highlighting its importance in maintaining metabolic homeostasis.
Recombinant ACSS3 protein is engineered using biotechnological methods, often expressed in *E. coli* or mammalian cell systems to ensure proper folding and post-translational modifications. The purified protein retains enzymatic activity, enabling researchers to study its kinetic properties, substrate specificity, and interactions with inhibitors or activators *in vitro*. Its recombinant form is essential for structural studies (e.g., X-ray crystallography or cryo-EM) to elucidate mechanisms underlying substrate binding and catalysis.
In biomedical research, ACSS3 recombinant protein is utilized to investigate metabolic pathways, screen potential therapeutic compounds for metabolic diseases, and explore its role in cancer progression, where altered acetyl-CoA levels influence epigenetic regulation and cell proliferation. Additionally, it serves as a tool to develop diagnostic assays for conditions associated with ACSS3 dysfunction.
Overall, ACSS3 recombinant protein is a valuable resource for advancing understanding of metabolic regulation and developing targeted therapies for related diseases.
×
